Literature DB >> 8885994

Lactacystin increases LDL receptor level on HepG2 cells.

H Miura1, H Tomoda, K Miura, K Takishima, S Omura.   

Abstract

Low density lipoprotein (LDL) receptor expression is regulated by proteolysis of transcription factors, sterol regulatory element binding proteins. To investigate the involvement of proteasome in this regulatory process, the effect of lactacystin, a specific proteasome inhibiton of microbial origin, was tested on LDL receptor expression on HepG2 cells. The addition of lactacystin to the cell culture increased the number of LDL receptors, indicating that proteasome plays a down-regulatory role in LDL receptor expression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8885994     DOI: 10.1006/bbrc.1996.1569

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Mutation G805R in the transmembrane domain of the LDL receptor gene causes familial hypercholesterolemia by inducing ectodomain cleavage of the LDL receptor in the endoplasmic reticulum.

Authors:  Thea Bismo Strøm; Kristian Tveten; Jon K Laerdahl; Trond P Leren
Journal:  FEBS Open Bio       Date:  2014-03-19       Impact factor: 2.693

2.  Inhibitory action of benzo[α]pyrene on hepatic lipoprotein receptors in vitro and on liver lipid homeostasis in mice.

Authors:  Hamed Layeghkhavidaki; Marie-Claire Lanhers; Samina Akbar; Lynn Gregory-Pauron; Thierry Oster; Nathalie Grova; Brice Appenzeller; Jordane Jasniewski; Cyril Feidt; Catherine Corbier; Frances T Yen
Journal:  PLoS One       Date:  2014-07-23       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.